Suppr超能文献

羟氯喹累积剂量与系统性红斑狼疮患者静息心率降低相关:一项初步研究。

Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.

作者信息

Cairoli E, Danese N, Teliz M, Bruzzone M J, Ferreira J, Rebella M, Cayota A

机构信息

Unidad de Enfermedades Autoinmunes Sistémicas, Clínica Médica 'C', Prof. Dr. Juan Alonso Bao, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay

Unidad de Enfermedades Autoinmunes Sistémicas, Clínica Médica 'C', Prof. Dr. Juan Alonso Bao, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay.

出版信息

Lupus. 2015 Oct;24(11):1204-9. doi: 10.1177/0961203315580870. Epub 2015 Apr 6.

Abstract

INTRODUCTION

The use of hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE) offers a wide range of benefits. However, there are evidence in favour of cardiotoxicity, including heart conduction disturbances and congestive heart failure.

OBJECTIVE

To determine the effects of HCQ in the resting heart rate (RHR) of SLE patients.

PATIENTS AND METHODS

Included were patients with non active SLE, with a sedentary lifestyle and treated with HCQ. Excluded were patients on beta blocker treatment, trained patients, pacemaker's users and patients with clinical or analytical evidence of anemia, renal disease, obstructive pulmonary disease, obesity, uncontrolled thyroid disease, fever or current infection. Standard 12-lead electrocardiogram was performed in the resting condition (supine decubitus and orthostatic position). Comparison between groups was performed using Mann-Whitney U test. A multiple linear regression was performed. A p value <0.05 was considered statistically significant.

RESULTS

42 patients were included. Patients were divided in two groups based on the cumulative dose of HCQ (CD-HCQ), considering 365 g as cut-off. There were 24 patients with low-HCQ (<365 g) and 18 patients with high-HCQ (>365 g). Non significant differences were found in age, sex, prednisone dose or SLEDAI. The mean RHR was 73 ± 6 beats/min in the low-HCQ and 65 ± 7 beats/min in the high-HCQ, with a significant decrease of 11% (p = 0.003). In multiple linear regressions, there were non significant association between the decrease of RHR and prednisone dose, age, SLEDAI or TSH, but there was significant association between RHR and CD-HCQ (p = 0.024) and RHR and time of exposure to HCQ (p = 0.029).

CONCLUSION

CD-HCQ higher than 365 g was associated with a significant decrease (11%) in RHR in non-active SLE patients, although a larger prospective study is required to allow more definitive conclusions.

摘要

引言

在系统性红斑狼疮(SLE)患者中使用羟氯喹(HCQ)有诸多益处。然而,有证据表明其存在心脏毒性,包括心脏传导障碍和充血性心力衰竭。

目的

确定HCQ对SLE患者静息心率(RHR)的影响。

患者与方法

纳入非活动期SLE患者,生活方式为久坐且接受HCQ治疗。排除使用β受体阻滞剂治疗的患者、受过训练的患者、起搏器使用者以及有贫血、肾病、阻塞性肺病、肥胖、未控制的甲状腺疾病、发热或当前感染的临床或分析证据的患者。在静息状态(仰卧位和直立位)下进行标准12导联心电图检查。组间比较采用曼-惠特尼U检验。进行多元线性回归分析。p值<0.05被认为具有统计学意义。

结果

共纳入42例患者。根据HCQ累积剂量(CD-HCQ)将患者分为两组,以365 g为界值。低剂量HCQ组(<365 g)有24例患者,高剂量HCQ组(>365 g)有18例患者。在年龄、性别、泼尼松剂量或SLE疾病活动指数(SLEDAI)方面未发现显著差异。低剂量HCQ组的平均RHR为73±6次/分钟,高剂量HCQ组为65±7次/分钟,显著降低了11%(p = 0.003)。在多元线性回归中,RHR降低与泼尼松剂量、年龄、SLEDAI或促甲状腺激素(TSH)之间无显著关联,但RHR与CD-HCQ之间存在显著关联(p = 0.024),RHR与HCQ暴露时间之间也存在显著关联(p = 0.029)。

结论

在非活动期SLE患者中,CD-HCQ高于365 g与RHR显著降低(11%)相关,尽管需要更大规模的前瞻性研究才能得出更明确的结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验